The tumult of large-scale cuts to federal spending, pullbacks of civil rights protections, and new tariffs getting announced ...

Further information on the abstracts that Roche will present at MDA 2025 can be found below.

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Ashton had been tormented by fear that he would be rejected by his family in the weeks leading up to his coming out in 2012.

Setting boundaries is healthy, but are you using them to control others? Learn how to spot toxic boundary-setting and build ...

Chinese scientists have developed a new treatment for nasopharyngeal carcinoma that helps patients live longer and have a ...

Dr Upul Wijayawardhana That it invariably leads to disaster when politicians attempt to tinker with what they know very little about is well illustrated by what is happening to the British National ...

The first patient has been enrolled in the PROSTATE-IQ trial of ArteraAI, a multimodal artificial intelligence biomarker test ...

Morgan said that every major health insurance provider currently is using AI in some way, both helpful and harmful to ...

AbbVie has pointed to a very strong launch trajectory for Elahere, with sales rocketing to $480 million last year, almost ...